Stay updated with breaking news from Nasdaq azyo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aziyo Biologics (NASDAQ:AZYO – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $8.00 target price on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 436.91% from the company’s previous close. […] ....
Cantor Fitzgerald reissued their overweight rating on shares of Aziyo Biologics (NASDAQ:AZYO – Free Report) in a report released on Tuesday morning, Benzinga reports. They currently have a $8.00 target price on the stock. Cantor Fitzgerald also issued estimates for Aziyo Biologics’ FY2023 earnings at ($2.13) EPS and FY2024 earnings at ($1.43) EPS. Aziyo Biologics […] ....
Aziyo Biologics (NASDAQ:AZYO – Get Free Report)‘s stock had its “overweight” rating reiterated by Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. They currently have a $8.00 price target on the stock. Cantor Fitzgerald’s price target suggests a potential upside of 430.82% from the company’s current price. Cantor Fitzgerald also issued estimates […] ....
Aziyo Biologics, Inc. (NASDAQ:AZYO – Get Rating) was the target of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 115,100 shares, a decrease of 28.4% from the April 30th total of 160,800 shares. Based on an average daily volume of 296,800 shares, the […] ....
Aziyo Biologics (NASDAQ:AZYO – Get Rating) had its price target trimmed by Cantor Fitzgerald from $12.00 to $10.00 in a research note published on Friday, The Fly reports. Aziyo Biologics Stock Performance NASDAQ AZYO opened at $2.24 on Friday. The stock’s 50 day moving average price is $2.22 and its two-hundred day moving average price […] ....